L'insuline détémir (Levemir®)BUYSSCHAERT, M.Louvain médical. 2005, Vol 124, Num 8, pp 340-344, issn 0024-6956, 5 p.Article

L'insuline detemirCHEIKEL, Jean.Diabétologie et facteurs de risque. 2004, Vol 10, Num 83, pp 45-49, issn 1267-6527, 5 p.Article

Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesisBÖHM, Anja; STAIGER, Harald; HENNIGE, Anita M et al.Regulatory peptides. 2008, Vol 151, Num 1-3, pp 160-163, issn 0167-0115, 4 p.Article

Insulin detemir, does a new century bring a better basal insulin?HORDERN, S. V. M; RUSSELL-JONES, D. L.International journal of clinical practice (Esher). 2005, Vol 59, Num 6, pp 730-739, issn 1368-5031, 10 p.Article

Le médicament du mois l'insuline détémir (Levemir®) = Insulin detemir (Levemir®)SCHEEN, A. J; RADERMECKER, R. P; PHILIPS, J. C et al.RMLG. Revue médicale de Liège. 2005, Vol 60, Num 10, pp 814-819, issn 0370-629X, 6 p.Article

Insulin detemir under steady-state conditions : no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetesBOTT, S; TUSEK, C; JACOBSEN, L. V et al.Diabetic medicine. 2006, Vol 23, Num 5, pp 522-528, issn 0742-3071, 7 p.Article

Refining basal insulin therapy : what have we learned in the age of analogues?DEVRIES, J. H; NATTRASS, M; PIEBER, T. R et al.Diabetes/metabolism research and reviews (Print). 2007, Vol 23, Num 6, pp 441-454, issn 1520-7552, 14 p.Article

Les nouvelles insulines : intérêts et inconvénients = New insulins : interests and convenientsSOLA, A; LARGER, E; M'BEMBA, J et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 6, pp 454-460, issn 1624-0693, 7 p.Article

Les analogues lents de l'insulineMAYAUDON, Hervé; LE BERRE, Jean-Philippe; BORDIER, Lyse et al.Diabétologie et facteurs de risque. 2005, Vol 11, Num 89, pp 14-19, issn 1267-6527, 6 p.Article

A double-blind, randomized, dose- response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemirPLANK, Johannes; BODENLENZ, Manfred; SINNER, Frank et al.Diabetes care. 2005, Vol 28, Num 5, pp 1107-1112, issn 0149-5992, 6 p.Article

Preoperative Hypoglycemia in a Patient Receiving Insulin DetemirOLSON, Ronald P; ANGELYN BETHEL, M; LIEN, Lillian et al.Anesthesia and analgesia. 2009, Vol 108, Num 6, pp 1836-1838, issn 0003-2999, 3 p.Article

Defining the Role of Insulin Detemir in Basal Insulin TherapyMORALES, Javier.Drugs (Basel). 2007, Vol 67, Num 17, pp 2557-2584, issn 0012-6667, 28 p.Article

Les analogues de l'insuline : la place de la détémir (Levemir®) = Insulin analogues : place of detemir (Levemir®)DORCHY, H; STERNON, J.Revue médicale de Bruxelles. 2006, Vol 27, Num 2, pp 89-94, issn 0035-3639, 6 p.Article

Insulin detemir compared with NPH insulin in children and adolescents with type 1 diabetesROBERTSON, K. J; SCHOENLE, E; GUCEV, Z et al.Diabetic medicine. 2007, Vol 24, Num 1, pp 27-34, issn 0742-3071, 8 p.Article

Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapyPIEBER, T. R; TREICHEL, H.-C; HOMPESCH, B et al.Diabetic medicine. 2007, Vol 24, Num 6, pp 635-642, issn 0742-3071, 8 p.Article

Les analogues de l'insuline : La place de la détémir (Levemir®) = Insulin analogues : place of detemir (Levemir®)DORCHY, H; STERNON, J.Journal de pharmacie de Belgique. 2006, Vol 61, Num 2, pp 58-62, issn 0047-2166, 5 p.Article

The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir InsulinCENGIZ, Eda; SWAN, Karena L; TAMBORLANE, William V et al.Diabetes care. 2012, Vol 35, Num 4, pp 690-692, issn 0149-5992, 3 p.Article

Insulin Detemir: A Review of its Use in the Management of Diabetes MellitusKEATING, Gillian M.Drugs (Basel). 2012, Vol 72, Num 17, pp 2255-2287, issn 0012-6667, 33 p.Article

Insulin detemir is not transported across the blood-brain barrierBANKS, William A; MORLEY, John E; LYNCH, Jessica L et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 12, pp 2284-2288, issn 0196-9781, 5 p.Article

An increased dose of insulin detemir improves glycaemic control and reduces body weight of Japanese patients with diabetesFUJII, H; WATANABE, Y; MIYAKAWA, T et al.International journal of clinical practice (Esher). 2010, Vol 64, Num 11, pp 1512-1519, issn 1368-5031, 8 p.Article

Insulin detemir: A new basal insulin analogGOLDMAN-LEVINE, Jennifer D; LEE, Karen W.The Annals of pharmacotherapy. 2005, Vol 39, Num 3, pp 502-507, issn 1060-0280, 6 p.Article

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes a randomized clinical trialHOME, Philip; BARTLEY, Paul; RUSSELL-JONES, David et al.Diabetes care. 2004, Vol 27, Num 5, pp 1081-1087, issn 0149-5992, 7 p.Article

Insulin detemir: A review of its use in the management of type 1 and 2 diabetes mellitusCHAPMAN, Therese M; PERRY, Caroline M.Drugs (Basel). 2004, Vol 64, Num 22, pp 2577-2595, issn 0012-6667, 19 p.Article

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetesPHILIS-TSIMIKAS, Athena; CHARPENTIER, Guillaume; CLAUSON, Per et al.Clinical therapeutics. 2006, Vol 28, Num 10, pp 1569-1581, issn 0149-2918, 13 p.Article

Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapyDAVIS, Keith L; TANGIRALA, Muralikrishna; MEYERS, Juliana L et al.Current medical research and opinion. 2013, Vol 29, Num 9, pp 1083-1091, issn 0300-7995, 9 p.Article